Significados de allotransplantation en inglés

Vascularized composite allotransplantation has been successfully employed for burn reconstruction since 2003.

Objectives: Xenotransplantation could be a future alternative to allotransplantation due to increasing organ shortage.

Since that time, 281 patients with acute leukemia have undergone allotransplantation at our Department.

Groups of mice were splenectomized at the day of allotransplantation.

High-risk patients (and standard-risk patients not mobilizing stem cells) underwent allotransplantation.

Therefore, conduct of a well-designed controlled clinical trial in the immediate future on allotransplantation is of paramount importance.

Acute rejection was absent after allotransplantation.

This experimental study was to show the difference and outcome of allotransplantation and autotransplantation of meniscus in dogs.

With evidence of transmission of novel viruses via allotransplantation, significant attention should be paid to emerging and as yet unknown viruses.

Conclusions: Long-term benefit and harms of allotransplantation is still unclear due to the clinical and statistical heterogeneity observed among the studies.

Background: Xenotransplantation represents one of alternative candidates for allotransplantation due to the chronic shortage of suitable human tissues; however, many obstacles remain.

Research in pig-to-primate xenotransplantation aims to solve the increasing shortage of organs for human allotransplantation and develop new cell- and tissue-based therapies.

Thirteen patients were treated with corticosteroids after allotransplantation, 21 other patients developed ocular symptoms while treated with steroids for serious systemic disorders.

This single-centre study investigated parameters that positively correlated with the success rate after islet allotransplantation in insulin-dependent diabetic (IDDM) patients.

The aim of this study was to systematically review the literature on the efficacy and safety of parathyroid allotransplantation to treat post-operative hypoparathyroidism.

In Germany allotransplantation of bone marrow or peripheral blood stem cells is presently performed by 34 different teams operating more or less independently.